Sarepta Therapeutics
SRPT
#1496
Rank
โ‚ฌ10.80 B
Marketcap
113,10ย โ‚ฌ
Share price
-0.18%
Change (1 day)
51.59%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ3.14 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total assets are โ‚ฌ3.14 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ2.95 B1.26%
2022-12-31โ‚ฌ2.91 B4.92%
2021-12-31โ‚ฌ2.77 B14.55%
2020-12-31โ‚ฌ2.42 B49.13%
2019-12-31โ‚ฌ1.62 B13.36%
2018-12-31โ‚ฌ1.43 B31.67%
2017-12-31โ‚ฌ1.09 B170.36%
2016-12-31โ‚ฌ0.40 B61.02%
2015-12-31โ‚ฌ0.25 B3.22%
2014-12-31โ‚ฌ0.24 B14.9%
2013-12-31โ‚ฌ0.21 B36.24%
2012-12-31โ‚ฌ0.15 B270.17%
2011-12-31โ‚ฌ41.86 M21.12%
2010-12-31โ‚ฌ34.56 M-17.5%
2009-12-31โ‚ฌ41.89 M129.37%
2008-12-31โ‚ฌ18.26 M-30.97%
2007-12-31โ‚ฌ26.46 M-14.55%
2006-12-31โ‚ฌ30.96 M-34.96%
2005-12-31โ‚ฌ47.61 M126.5%
2004-12-31โ‚ฌ21.02 M-43.86%
2003-12-31โ‚ฌ37.44 M36.85%
2002-12-31โ‚ฌ27.36 M-28.54%
2001-12-31โ‚ฌ38.28 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ49.23 B 1,464.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.67 B-46.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.23 B-60.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.43 B-86.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.68 B 17.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.76 B-44.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.66 B-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA